XPAR
IDIP
Market cap587mUSD
Jul 09, Last price
72.00EUR
1D
0.84%
1Q
3.45%
Jan 2017
176.92%
Name
IDI SCA
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
IDI, a Paris-based private equity firm established in 1970, employs a diverse range of investment strategies. The company focuses on leveraged buyouts, providing growth capital, and engaging in middle-market transactions. Its activities extend to acquiring substantial stakes in publicly listed small and medium-sized enterprises, managing secondary private equity portfolios, and offering various debt solutions including mezzanine financing, senior-to-senior loans, and discounted LBO loans for established businesses. Furthermore, IDI participates in co-investments for pre-initial public offering (IPO) financing rounds. Beyond direct investments, the firm also operates as a fund-of-funds, allocating capital to both private equity and hedge funds across all sectors, with a primary geographic focus on France and other developed European markets. IDI typically makes equity investments ranging from $0.58 million to €150 million. It targets companies with an enterprise value between €10 million and €300 million, reserving the flexibility to exceed this limit on a case-by-case basis. Individual deal commitments generally range from €5 million to €25 million. The firm seeks companies generating annual revenues between $13.25 million and $530.18 million. For its fund-of-funds activities, IDI looks for funds with sizes from $50 million to €300 million. While open to minority positions, IDI generally prefers to secure majority ownership, particularly in small and medium-sized companies acquired via leveraged buyouts. Notably, the firm primarily funds both its direct and fund-of-funds investments using its proprietary capital.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||